Rituximab in relapsed aggressive lymphoma: play it again, Sam?

Leuk Lymphoma. 2010 Mar;51(3):355-6. doi: 10.3109/10428191003682791.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Disease-Free Survival
  • Doxorubicin / administration & dosage
  • Humans
  • Immunotherapy / methods
  • Lymphoma / drug therapy*
  • Lymphoma / pathology*
  • Medical Oncology / methods*
  • Prednisolone / administration & dosage
  • Recurrence
  • Rituximab
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone

Supplementary concepts

  • VAP-cyclo protocol